Skip to main content
. 2024 Nov 29;16(23):4005. doi: 10.3390/cancers16234005

Table 1.

Definitions of clinically relevant gonadotoxicity.

Females Males
Menstrual cycle disorders
Amenorrhea/oligomenorrhea
Hormonal treatment: puberty induction/hormonal replacement therapy
Disorders of sperm quality
Azoospermia
Oligozoospermia
Hormone levels above the normal range
Follicle-stimulating hormone (FSH)
Luteinizing hormone (LH)
Hormone levels above the normal range
Follicle-stimulating hormone (FSH)
Luteinizing hormone (LH)
Premature ovarian insufficiency (POI)
Oligo-/amenorrhea for at least 4 months and
an elevated FSH level > 25 IU/L on two occasions at 4 weeks apart before the age of 40.
(ESHRE Definition)
Gonadal dysfunction
Low testosterone levels
Hormonal treatment: testosterone therapy
Low ovarian reserve parameters
Anti-Müllerian hormone (AMH) not detectable
Hormone levels below the normal range
Inhibin B